Ellicott City, MD – The Society for Clinical Research Sites (SCRS) announces Acurian as the corporate sponsor for the SCRS Ambassador Program in Poland. The SCRS Site Ambassador Program brings SCRS benefits to sites in countries around the world. SCRS currently has site members in 49 countries. Countries (in some cases, regions) with an SCRS Site Ambassador receive quarterly SCRS seminars focused on the interests of sites in that area.	 	“Acurian has taken a leadership position in the Ambassador Program by supporting our efforts in Poland,” said Christine Pierre, President of SCRS. “We look forward to supporting site sustainability in Poland and around the world as the SCRS Ambassador Program grows.”	 	“We recognize that sites in Poland are increasingly crucial partners in the effort to successfully enroll global clinical trial programs we support,” said Todd Albin, Senior Director of Site Enrollment Optimization at Acurian, a subsidiary of PPD, a leading global contract research organization. “SCRS has been the global leader in advocating for the sustainability of sites throughout the world. We are very excited to be part of this ambassador program and help introduce Polish sites to SCRS and Acurian so that they can benefit from the variety of ways both of our organizations contribute to their long-term success.”	 	

	SCRS is a global trade organization founded in 2012 which represents over 3,000 research sites in 49 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit 

	Acurian, a subsidiary of PPD, is a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry. The company increases the enrollment performance of investigator sites worldwide by identifying, contacting, prescreening and referring people who live in the local community but are unknown to a research site. As a result, trial sponsors complete enrollment without incurring the unexpected expense of adding sites or time. For more information, visit 